When was Intelliseq founded?

Intelliseq was founded in 2014 and raised its 1st funding round 8 years after it was founded.

Where is Intelliseq located?

Intelliseq is headquartered in Krakow, Poland.

Who is the current CEO of Intelliseq?

Klaudia Szklarczyk Smolana of Intelliseq. They have also founded 1 company.

How many employees does Intelliseq have?

As of Aug 31, 2026, the latest employee count at Intelliseq is 16.

Is Intelliseq a funded company?

Intelliseq is a funded company, having raised a total of $6.45M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 07, 2022.

When was the latest funding round of Intelliseq?

Intelliseq's latest funding was a €***** Series A round on Mar 28, 2025, with participation from 2 investors.

Where does Intelliseq rank among its competitors?

Intelliseq ranks 76th amongst 759 active competitors, of which 135 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was SeqOne, which secured $22.7M in May, 2025.

Who are the top competitors of Intelliseq?

Intelliseq's top competitors include Benchling, Helix and Congenica. Among them, SeqOne secured the most recent funding round in May, 2025.

Intelliseq - 2026 Company Profile, Team, Funding, Competitors & Financials

Intelliseq is a series A company based in Krakow (Poland), founded in 2014 by Sławomir Gołda and Klaudia Szklarczyk Smolana. It operates as a Provider of software for NGS data analysis. Intelliseq has raised $6.45M in funding from YouNick Mint and Vinci. The company has 759 active competitors, including 135 funded and 56 that have exited. Its top competitors include companies like Benchling, Helix and Congenica.

Company Details

Provider of software for NGS data analysis. The domain is offering bioinformatics software used for NGS data analysis. It allows users to upload the DNA data which is should be analyzed by the platform to provide the required results. It can also be used for genetic diseases, hereditary cancer, carrier screening, pharmacogenetics, and genome-wide association studies.

Website: intelliseq.com
Social
Email ID: *****@intelliseq.com

Key Metrics

Founded Year

2014

Location

Krakow, Poland

Stage

Series A

Total Funding

$6.45M in 2 rounds

Latest Funding Round

Series A, Mar 28, 2025, €*****

Investors

YouNick Mint & 4 more

Ranked

76^th among 759 active competitors

Employee Count

16 as on Aug 31, 2026

Similar Companies

Benchling & 998 more

View Intelliseq's full profile

Intelliseq is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Intelliseq Sp. z o.o CIN: 0000524323 , Poland, Active	Sep 21, 2014	-	-

Intelliseq has raised a total funding of $6.45M over 2 rounds. Its first funding round was on Nov 07, 2022. Its latest funding round was a Series A round on Mar 28, 2025 for €*****. 2 investors participated in its latest round. Intelliseq has 4 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Intelliseq:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 28, 2025	4142100	Series A	8198822	7258526	5293497	6673293
Nov 07, 2022	2320165	Seed	6994742	6098863	YouNick Mint	Unfold.vc & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of Intelliseq's funding rounds and investors

The founders of Intelliseq are Sławomir Gołda and Klaudia Szklarczyk Smolana. Klaudia Szklarczyk Smolana is the CEO of Intelliseq.

Here are the details of Intelliseq's key team members:

Sławomir Gołda: Co-Founder of Intelliseq.
Contact Info: 1 email address
Klaudia Szklarczyk Smolana: Co-Founder & CEO of Intelliseq.
Contact Info: 1 email address

View details of Intelliseq's Founder profiles and Board Members

Intelliseq's employee count trend

Intelliseq has 16 employees as of Aug 26. Here is Intelliseq's employee count trend over the years:

Uncover Intelliseq's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Intelliseq include Benchling, Helix and Congenica. Here is the list of Top 10 competitors of Intelliseq, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Draper & 28 others	73/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
3rd	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	IDO Investments, Tencent & 39 others	62/100
4th	Hexagon Bio 2017, Menlo Park (United States), Series B	Provider of bioinformatics tools for the analysis of microbial genomic sequencing data	$206M	Nextech Invest, The Column Group & 10 others	62/100
5th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
6th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	58/100
7th	BC Platforms 1997, Zurich (Switzerland), Series D	Provider of a platforms for genomic data analysis and management	$47.1M	Jolt Capital, Debiopharm & 6 others	58/100
8th	SeqOne 2017, Montpellier (France), Series A	Provider of bioinformatics tools for the analysis of genome sequencing data	$48.8M	Elaia, Omnes Capital & 7 others	57/100
9th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	57/100
10th	Genedata 1997, Basel (Switzerland), Acquired	Software solutions for drug discovery, industrial biotechnology, and life science research	-	Novartis Venture Fund, Alta Partners & 1 others	56/100
76th	Intelliseq 2014, Krakow (Poland), Series A	Provider of software for NGS data analysis	$6.45M	Unfold.vc, Cobin Angels & 3 others	39/100